Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts, Incontinence, prolapse & sacral neuromodulation, Hernia repair.
All companies · Product and company coverage
In the last ten years FDA made 2 decisions for Coloplast (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2024 (1). The latest was on 2024-03-22.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 15 |
| Incontinence, prolapse & sacral neuromodulation | 9 |
| Hernia repair | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-03-22 | 510(k) | K231953 | Biatain Fiber Ag (33570 - 5 cm x 5 cm / 2 in x 2 in); Biatain Fiber Ag (33572 - 10 cm x 12 cm / 4 in x 5 in); Biatain Fiber Ag (33574 - 15 cm x 15 cm / 6 in x 6 in); Biatain Fiber Ag (33576 - 2.5 cm x 46 cm / 1 in x 18 in); Biatain Fiber Ag (33578 - 20 cm x 30 cm / 8 in x 12 in) |
| 2020-02-21 | 510(k) | K191536 | Biatain Silicone Ag |
| 2014-02-12 | 510(k) | K140116 | RESTORELLE Y CONTOUR MESH |
| 2013-08-02 | 510(k) | K132061 |
In 2025, Coloplast reported engagement with 6,143 surgeons and other clinicians in the states MedaRep covers, worth $2.7M in consulting, speaking, meals and travel for its device products, the most in Florida ($573K to 755). Royalties are left out.
| RESTORELLE M, RESTORELLE XL |
| 2013-03-05 | 510(k) | K123914 | RESTORELLE Y CONTOUR |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Coloplast.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Florida ($573K, 755 engaged), Texas ($266K, 429 engaged), New York ($224K, 379 engaged), Ohio ($177K, 200 engaged), California ($154K, 392 engaged).